Source: The Wall Street Journal By AUSTEN HUFFORD Updated March 30, 2016 11:45 a.m. ET Valeant Pharmaceuticals International Inc. sought some room to maneuver Wednesday, asking its lenders to relax some debt-covenant terms and give it an additional month to file its delayed annual report. The Canadian drug company said…...